Could a Low-Dose drug ease chronic fatigue and Long-COVID?
Disease control
ENROLLING_BY_INVITATION
This study looks at whether low dose rapamycin can reduce symptoms and improve quality of life in people with ME/CFS or Long-COVID. Researchers will track symptom changes and measure blood markers related to cell cleanup (autophagy). 150 participants will take rapamycin prescribe…
Sponsor: Simmaron Research Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC